Regenerative Medicine Market Size, Share, Outlook, Industry Analysis Report 2020

The Research Report on "Regenerative Medicine Market by Product (Cell Therapies (Autologous, Allogenic), Stemcell Therapy, Tissue-engineering, Gene Therapy), Application (Wound Care, Musculoskeletal, Oncology, Dental, Ocular), Geography - Global Forecast to 2025", is projected to reach USD 17.9 billion by 2025 from USD 8.5 billion in 2020, at a CAGR of 15.9%.

Growth Driver: Growing prevalence of chronic diseases, genetic disorders, and cancer;

Over the last few decades, the incidence and prevalence of chronic diseases such as CVD, cancer, diabetes, ulcers, and genetic disorders such as cystic fibrosis have increased significantly across the globe. Diabetes and obesity can result in the increased incidence and complexity of wounds such as infections, ulcerations (leg or foot ulcers), and surgical wounds, which require treatments and incur exorbitant medical expenses.

Growth Opportunity: Implementation of the 21st Century Cures Act;

The 21st Century Cures Act was signed into law in the US in December 2016. Among other objectives, this new law has been enacted to advance regenerative medicine research and medical innovation and covers various provisions that may impact the development and approval of several products in the coming years.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65442579

Industry Segmentation In Detailed:

The tissue-engineered products segment accounted for the largest share of the regenerative medicine market, by product segment, in 2019

Based on products, segmented into tissue-engineered products, cell therapies, gene therapies, and progenitor and stem cell therapies. The tissue-engineered products segment accounted for the largest share in the regenerative medicine market in 2019. The increasing adoption of tissue-engineered products for the treatment of chronic wounds and musculoskeletal disorders and the rising funding for the R&D of regenerative medicine products and therapies are the major factors driving the growth of this segment.

Oncology segment to register the highest growth rate during the forecast period

Based on applications, the regenerative medicine market is segmented into musculoskeletal disorders, wound care, oncology, ocular disorders, dental, and other applications. In 2019, the oncology segment accounted for the highest growth rate. This can be attributed to the rising prevalence of orthopedic diseases, growing geriatric population, increasing number of stem cell research projects, growing number of clinical researches/trials, and the rich pipeline of stem cell products for the treatment of musculoskeletal disorders.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=65442579

Leading Key Players and Analysis:

The major players operating in Regenerative Medicine Market are 3M (US), Allergan plc (Ireland), Amgen, Inc. (US), Aspect Biosystems (Canada), bluebird bio (US), Kite Pharma (US), Integra LifeSciences Holdings Corporation (US), MEDIPOST Co., Ltd. (South Korea), Medtronic plc (Ireland), Anterogen Co., Ltd. (South Korea), MiMedx Group (US), Misonix (US), Novartis AG (Switzerland), Organogenesis Inc. (US), Orthocell Limited (Australia), Corestem, Inc. (South Korea), Spark Therapeutics (US), APAC Biotech (India).

Novartis AG (Switzerland) Novartis AG is one of the the largest player in the regeneartive medicine market in 2019. In order to maintain its position in the market, the company has been focusing on the innovations, and breakthrough product approvals for the treatment of cancer. For instance, in August 2017, Novartis received the FDA approval for CAR-T cell therapy, Kymriah (CTL019), which is used for the treatment of cancer. Kymriah got the EU approval in August 2018. Novartis also focused on the inorganic strategies in order to enhance their dominance in the regenerative medicine market. For instance, Novartis received EU approval for one-time gene therapy, Luxturna, developed by Spark Therapeutics, to restore vision in people with rare and genetically-associated retinal disease.

Geographical Analysis in Detailed:

The regenerative medicine market is segmented into four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2019, North America accounted for the largest share in the market. The growth in the North American market can be attributed to rising stem cell banking, tissue engineering, and drug discovery in the region; expansion of the healthcare sector; and the high adoption of stem cell therapy and cell immunotherapies for the treatment of cancer and chronic diseases.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=65442579

Global Depth Filtration Market Revenue, Demand, Opportunity, Segment and Key Trends 2019

The Growth of Depth Filtration Market is propelled by the increasing demand for biopharmaceuticals and increasing R&D expenditure in the biopharmaceutical industry.

On the other hand, stringent government regulations are expected to restrain the growth of this market to a certain extent during the forecast period. In addition, the low capacity of depth filters in high-density harvest is the major challenge in the Depth Filtration Market.

provides a detailed overview of major drivers, restraints, challenges, opportunities, current market trends and strategies impacting the global market along with estimates and forecast of revenue.

The Global Depth Filtration Market is poised to reach USD 2.96 Billion, at a CAGR of 11.7%.

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=143876285

The Global Depth Filtration Market research report categorizes the market on the basis of media type, product, application, and region.

based on application broadly classified into final product processing, cell clarification, raw material filtration, and other applications (such as water purification and viral clearance). The final product processing segment is further divided into small molecule processing and biologics processing. Similarly, the raw material filtration segment is further categorized into media & buffer filtration and bioburden testing.

Depth Filtration Market Growth Drivers;

· Growth in the Production of Biologics and Large Molecules

· Increasing R&D Expenditure in Pharmaceutical and Biopharmaceutical Companies

· Advantages Such as Low Cost and Ease of Use are Driving the Uptake of Depth Filters

· merging Markets Offer Lucrative Growth Opportunities

Request Research Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=143876285

Geographical Analysis:

North America (comprising the U.S. and Canada) is expected to account for the largest share of the global Depth Filtration Market, followed by Europe. North America is the world’s largest pharmaceutical market and a leader in biopharmaceutical research. Rising quality requirements have emphasized the need for advanced bioproduction technology in this region. Asia-Pacific is expected to grow at the highest CAGR in the forecast period.

• Further breakdown of the APAC Depth Filtration Market into China, Japan, India, and Rest of Asia-Pacific
• Further breakdown of the European Depth Filtration Market into Germany, France, the U.K., and Rest of Europe

Some of the Major Key Players Operating in the Market;

The Depth Filtration Market is dominated by established players such as Merck KGaA (Germany), Sartorius Stedim Biotech S.A. (France), and Pall Corporation (U.S.).

Speak to Our Subject Expert:

https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=143876285

Merck Millipore KGaA (Germany) was one of the leading players offering depth filter cartridges. The company has strengthened its position in the market through the adoption of organic as well as inorganic strategies such as expansions and acquisitions. Between 2015 and 2017, the company acquired companies to complement its product portfolio and expand its reach. For instance, in 2015, Merck KGaA acquired Sigma Aldrich (U.S.). With this acquisition, the company enhanced its product range & capabilities and expanded its geographic reach & customer base.